NDC 0061-0387 - Otomax
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0061-0387
- Package NDCs from labels
- 0061-0387-02, 0061-0387-03, 0061-0387-17, 0061-0387-08, 0061-0387-01
- Manufacturer
- Merck Sharp & Dohme Corp.
- Effective date
- 2026-05-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Otomax - Merck Sharp & Dohme Corp. | Merck Sharp & Dohme Corp. | 2026-05-18 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0061-0387-01 | Otomax | 215 g in 1 BOTTLE, PLASTIC | OINTMENT | 215 | 10 | |
| 0061-0387-01 | Otomax | 1 in 1 CARTON | OINTMENT | 1 | 10 | |
| 0061-0387-02 | Otomax | 7.5 g in 1 TUBE | OINTMENT | 7.5 | 10 | |
| 0061-0387-02 | Otomax | 1 in 1 CARTON | OINTMENT | 1 | 10 | |
| 0061-0387-03 | Otomax | 1 in 1 CARTON | OINTMENT | 1 | 10 | |
| 0061-0387-03 | Otomax | 15 g in 1 TUBE | OINTMENT | 15 | 10 | |
| 0061-0387-08 | Otomax | 1 in 1 CARTON | OINTMENT | 1 | 10 | |
| 0061-0387-08 | Otomax | 30 g in 1 BOTTLE, PLASTIC | OINTMENT | 30 | 10 | |
| 0061-0387-17 | Otomax | 1 in 1 CARTON | OINTMENT | 1 | 10 | |
| 0061-0387-17 | Otomax | 15 g in 1 BOTTLE, DISPENSING | OINTMENT | 15 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Betamethasone valerate | ACTIVE INGREDIENT | 9IFA5XM7R2 | OTOMAX (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE) OINTMENT [MERCK SHARP & DOHME CORP.] | 1 | |
| Clotrimazole | ACTIVE INGREDIENT | G07GZ97H65 | OTOMAX (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE) OINTMENT [MERCK SHARP & DOHME CORP.] | 1 | |
| Gentamicin Sulfate | ACTIVE INGREDIENT | 8X7386QRLV | OTOMAX (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE) OINTMENT [MERCK SHARP & DOHME CORP.] | 1 | |
| Betamethasone | ACTIVE MOIETY | 9842X06Q6M | OTOMAX (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE) OINTMENT [MERCK SHARP & DOHME CORP.] | 1 | |
| Clotrimazole | ACTIVE MOIETY | G07GZ97H65 | OTOMAX (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE) OINTMENT [MERCK SHARP & DOHME CORP.] | 1 | |
| Gentamicin | ACTIVE MOIETY | T6Z9V48IKG | OTOMAX (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE) OINTMENT [MERCK SHARP & DOHME CORP.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Femmesil | CLOTRIMAZOLE | Aidance Skincare & Topical Solutions, LLC | efddad82-9dc7-4cd9-b33c-7e85f30d992e | 2024-05-24 | Warnings | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | QUALITY CHOICE (Chain Drug Marketing Association) | 3c676ff0-44a8-40cd-8f85-d39dda3d9637 | 2024-05-23 | Warnings | G07GZ97H65 |
| Up and Up Athletes Foot | CLOTRIMAZOLE 1% | Target Corporation | 52b61859-11ae-4990-aa0c-9dc1dd00adf4 | 2024-05-08 | Warnings | G07GZ97H65 |
| Betamethasone Valerate | BETAMETHASONE VALERATE | Padagis Israel Pharmaceuticals Ltd | dc5dfd3e-7762-40c8-880e-c7db80d87749 | 2024-03-31 | Warnings, Adverse reactions | 9IFA5XM7R2 |
| Clotrimazole Antifungal | CLOTRIMAZOLE | Trifecta Pharmaceuticals USA, LLC. | 11bf50db-552e-0a39-e063-6394a90af60d | 2024-02-19 | Warnings | G07GZ97H65 |
| GENTAMICIN | GENTAMICIN | HF Acquisition Co LLC, DBA HealthFirst | c1ff0cdc-ac5d-30ca-e053-2a95a90a5066 | 2024-01-30 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| GENTAMICIN SULFATE | GENTAMICIN SULFATE | HF Acquisition Co LLC, DBA HealthFirst | e9fbe619-2afe-f1d7-e053-2a95a90aab29 | 2024-01-27 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Target Jock Itch | CLOTRIMAZOLE 1% | Target Corporation | f44d4c44-99d1-413f-b9c3-8330bdd21abb | 2024-01-17 | Warnings | G07GZ97H65 |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Padagis Israel Pharmaceuticals Ltd | a9486ae1-350b-41c5-ae0c-a4d692bb2dfd | 2024-01-15 | Adverse reactions | 8X7386QRLV |
| gentamicin sulfate | GENTAMICIN SULFATE | DIRECT RX | 51a411a0-2671-4c1c-bf25-e29b32efed0c | 2024-01-10 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Sandoz Inc | a213fb9c-08ea-4f30-a6c9-93c7a9ba5280 | 2024-01-02 | Warnings, Adverse reactions | 8X7386QRLV |
| clotrimazole | CLOTRIMAZOLE | Proficient Rx LP | eeb241a3-93ee-4b74-8cbb-65713d15e7e0 | 2024-01-01 | Warnings | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Proficient Rx LP | ba1dc4a4-073f-4f30-bb9c-9ed043700431 | 2024-01-01 | Warnings | G07GZ97H65 |
| RUGBY ANTIFUNGAL CLOTRIMAZOLE | CLOTRIMAZOLE | Proficient Rx LP | 7c64553b-589c-4e65-a6f0-b2847bbbe8a6 | 2024-01-01 | Warnings | G07GZ97H65 |
| Gentamicin | GENTAMICIN | Fresenius Kabi USA, LLC | 8bdeef7f-ad8e-46e0-a872-e945eae51d68 | 2023-12-20 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Betamethasone Valerate | BETAMETHASONE VALERATE | A-S Medication Solutions | f8711d17-de6a-45e3-8027-b650308207ed | 2023-12-15 | Adverse reactions | 9IFA5XM7R2 |
| Betamethasone Valerate | BETAMETHASONE VALERATE | A-S Medication Solutions | d265d143-343f-41ec-9cb4-18d83edb772b | 2023-12-12 | Adverse reactions | 9IFA5XM7R2 |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Cosette Pharmaceuticals, Inc. | 16474069-510b-0754-9d78-9bc0354f6549 | 2023-11-23 | Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Cosette Pharmaceuticals, Inc. | 9e550dc9-509e-da05-8a97-ecbd0f5dd633 | 2023-11-22 | Adverse reactions | 8X7386QRLV |
| Antifungal Cream | ANTIFUNGAL | BluePoint Laboratories | b4c4240f-f84c-ec5e-e053-2a95a90aa082 | 2023-11-17 | Warnings | G07GZ97H65 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.